How to Buy Inovio Pharmaceuticals Stock
Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals, Inc. , a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.
Inovio Pharmaceuticals stock last closed at $5.55, down 1.77% from the previous day, and has increased 24.3% in one year. It has overperformed other stocks in the Biotechnology industry by 0.35 percentage points. Inovio Pharmaceuticals stock is currently +42.75% from its 52-week low of $3.89, and -62.37% from its 52-week high of $14.75.
As of Oct 4, 2024, there are 25.96M shares of INO outstanding. The market capitalization of INO is $144.10M. In the last 24 hours, 369,609 INO shares were traded.
How to Buy Inovio Pharmaceuticals Stock
Not sure how to invest in Inovio Pharmaceuticals stock? Here's how.
- Figure out where to buy Inovio Pharmaceuticals stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you determine where to buy Inovio Pharmaceuticals stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Select your method of payment and add your information.
- Analyze Inovio Pharmaceuticals stock: The Inovio Pharmaceuticals ticker symbol is INO. Is Inovio Pharmaceuticals stock a good investment? Should you buy shares of INO? How do INO's underlying business fundamentals look? Do top analysts think Inovio Pharmaceuticals is a good buy? Why has INO's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if INO is a good stock to buy).
- Make your INO trade: Decide if you will purchase INO shares at the current market price or use a limit order to purchase INO shares at a specific price.
- Keep an eye on your investment in INO: Create a watchlist to key updates about your new investment in Inovio Pharmaceuticals stock.
Step 1: Figure out where to buy Inovio Pharmaceuticals stock
You will need an online brokerage account in order to access the NASDAQ market and buy INO stock.
Our favorite brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Real Estate, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro today.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal information so you can buy INO today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to open your new brokerage account.
- Submit your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've filled out your info on the stock trading app, you need to deposit funds:
Watch the video below to see the process of depositing funds into your investment account.
Step 4: Analyze Inovio Pharmaceuticals stock
Once you have selected the best place to buy Inovio Pharmaceuticals stock, it's important to evaluate their stock prior to buying, so you actually wrap your head around the risk as well as the opportunity.
Inovio Pharmaceuticals Metrics
Fundamentals of Inovio Pharmaceuticals
WallStreetZen was built to help average investors do more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on INO's stock page.
What is the fair value of INO stock?
Analysts use many financial metrics, analyses, models, and charts to gauge INO's fair value.
Using relative valuations metrics:
- INO may be undervalued based on its P/B ratio of 1.49x, relative to Biotechnology industry P/B ratio of 5.96x
You can do more valuation analysis on INO's stock here.
INO Financial Health Overview
Positive Health Checks:
- INO has a low debt to equity ratio of 0.38.
- There are more short-term assets than short-term liabilities on the INO balance sheet.
- INO has $110.42M in cash and short term investments. This is sufficient to cover its annual cash burn of $112.70M.
- Total INO debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the INO balance sheet.
Negative Health Checks:
- INO profit margin has gone down from -1,750.9% to -20,552.3% in the past year.
- INO has cash burn of 112695292. It does not have enough cash and short-term investments to cover this.
Is Inovio Pharmaceuticals stock a Buy, Hold, or Sell, according to analysts?
Out of 4 Wall Street analysts who research INO, the consensus analyst rating on Inovio Pharmaceuticals is a Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Inovio Pharmaceuticals stock forecast page.
Metrics for Advanced INO Traders
INO Performance Metrics
Last year, INO revenue was $591.86k. In the past 5 year, INO's revenue has grown by -39.77% per year. This was slower than the Biotechnology industry average of 61.66%.
Learn more about INO's earnings and revenue performance here.
Who is buying/selling INO?
In the last year, insiders at INO have sold more shares than they have bought.
Laurent Humeau, Chief Scientific Officer of INO, was the latest INO insider to sell. They sold $22,258.21 worth of INO stock on May 15, 2024.
Dig into more about who owns INO stock here.
Can I get consistent income from INO stock?
No, Inovio Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your INO trade
There are two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally fine for most investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a particular dollar amount, place a limit order.
Hit the Open Trade button and your broker will place your order.
If you need more help investing in stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your investment in INO
Now that you own some shares in INO, you'll want to keep up with your new investment.
Make a watchlist to keep tabs on your INO stock.
INO Feed
How to Buy Stock in Inovio Pharmaceuticals
To reiterate, here are the 6 steps you need to take to buy Inovio Pharmaceuticals stock right now:
- Figure out where to buy Inovio Pharmaceuticals stock
- Create a brokerage account
- Put funds into your brokerage account
- Analyze Inovio Pharmaceuticals stock
- Make your INO trade
- Keep an eye on your investment in INO
If you require a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep track of your new investment in Inovio Pharmaceuticals, add INO to your watchlist below.
Other Stock Buying Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.